By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Koningin Wilhelminalaan 22

Driebergen    3972 EX  The Netherlands
Phone: 31-655-764-221 Fax:


Company News
Merus Appoints Mark Iwicki As President Of The Supervisory Board 6/1/2015 10:09:47 AM
Novartis Pharma AG (NVS) Unloads Certain Specialty Product Rights to Merus for $29.5 Million 5/22/2015 5:19:32 AM
Merus And Selexis SA Receive A € 2.1 Million Grant For Single Cell Line Manufacturing Of A Bispecific Antibody Combination To Treat Colorectal Cancer 5/20/2015 10:07:20 AM
Merus Reaches Pivotal Milestone In Bispecific Antibody Collaboration With Ono Pharmaceutical Company, Ltd. 4/8/2015 10:02:22 AM
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014 10:54:54 AM
ProBioGen AG And Merus Sign Deal On GlymaxX® ADCC Enhancement Technology 3/4/2014 9:46:09 AM
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013 10:25:18 AM
Merus Lands $42 Million Series B 10/3/2013 6:48:02 AM
Merus Presents Preclinical Data on Its Novel Bispecific Antibody MCLA-117 at European Hematology Association 2013 6/17/2013 8:56:07 AM
SUPPRESTEM Consortium Led by Merus Receives $7.7 Million FP7 Grant From the European Union 5/28/2013 9:52:28 AM